4
FDMT
4D Molecular Therapeutics Inc.
9.02
-0.15-1.64%After Hours: 8.84 -0.18 -2.00%16:05 02/20 EST
OPEN/PREV CLOSE9.03/9.17
TODAY RANGE8.81-9.23
VOL657.42K
MARKET CAP460.09M
52 WEEK RANGE2.235-12.34
AVG VOL (3M)897.66K
% TURNOVER1.29%
TURNOVER--
P/E (TTM)-2.4092
% RANGE4.58%
EPS(TTM)-3.7440
P/E(FORWARD)-2.4578
P/B1.143
BVPS7.89
DIVIDEND--
P/S11,275.00
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP443.38M
SHARES OUTSTANDING51.01M
NEXT EARNINGS02/26-03/02
FREE FLOAT49.15M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Reuters·02/13 21:05
4D Molecular Therapeutics Grants 124,200 RSUs to New Employees
TipRanks·02/09 13:26
4D Molecular completes enrollment for 4FRONT-1 Phase 3 trial
Benzinga·01/28 14:01
Deep Dive Into 4D Molecular Therapeutics Stock: Analyst Perspectives (5 Ratings)
Dow Jones·01/28 13:47
4D Molecular Therapeutics Price Target Announced at $33.00/Share by Barclays
Dow Jones·01/28 13:47
4D Molecular Therapeutics Initiated at Overweight by Barclays
TipRanks·01/27 21:27
4D Molecular assumed with an Overweight at Barclays
TipRanks·01/26 21:36
4D Molecular Therapeutics Restructures Equity via Warrant Exchange
TipRanks·01/19 18:35
4D Molecular announces employment inducement grants
Same Industry
Name/Symbol
Change%
Price